PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER

被引：0
|
作者：
Gulec, U. Kucukgoz [1 ]
Bagir, E. [2 ]
Paydas, S. [3 ]
Seydaoglu, G. [4 ]
Guzel, A. B. [1 ]
Vardar, M. A. [1 ]
机构：
[1] Cukurova Univ, Sch Med Obstet & Gynecol, Adana, Turkey
[2] Cukurova Univ, Sch Med, Pathol, Adana, Turkey
[3] Cukurova Univ, Sch Med, Med Oncol, Adana, Turkey
[4] Cukurova Univ, Sch Med, Biostat, Adana, Turkey
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-1355
引用
收藏
页码：1127 / 1127
页数：1
相关论文
共 50 条
  • [21] Programmed death-ligand 1 (PD-L1) expression in pheochromocytoma.
    Hashimoto, Yasuhiro
    Yamamoto, Hayato
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [22] Expression pattern of immune checkpoints programmed death (PD-1) and programmed death-ligand (PD-L1) in retinoblastoma and its prognostic significance
    Singh, L.
    Kashyap, S.
    Pushker, N.
    Bakhshi, S.
    Sen, S.
    Rizvi, M. A.
    ANNALS OF ONCOLOGY, 2017, 28 : 11 - 11
  • [23] Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
    Guzik, Katarzyna
    Zak, Krzysztof M.
    Grudnik, Przemyslaw
    Magiera, Katarzyna
    Musielak, Bogdan
    Torner, Ricarda
    Skalniak, Lukasz
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5857 - 5867
  • [24] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [25] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
  • [26] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2019, 99
  • [27] Programmed Death-ligand 1 (PD-L1) Expression in Thymic Epithelial Tumors
    Bedekovics, Judit
    Beke, Livia
    Mokanszki, Attila
    Szilagyi, Szabolcs
    Mehes, Gabor
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 1 - 9
  • [28] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2019, 32
  • [29] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569
  • [30] Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) expression in bladder cancer (BC): Differences in recurrent, progressive, and metastatic disease.
    Hegele, Axel
    Wahl, Franziska
    Rexin, Peter
    Nimphius, W.
    Hofmann, Rainer
    Haenze, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345